PainReform Ltd. (PRFX) NASDAQ

1.38

+0.02(+1.47%)

Updated at October 03 04:00PM

Currency In USD

PainReform Ltd.

Address

65 Yigal Alon Street

Tel Aviv, 6745442

Israel

Phone

972 3 717 7050

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2

First IPO Date

September 01, 2020

Key Executives

NameTitlePayYear Born
Dr. Ehud Geller Ph.D.Interim Chief Executive Officer & Executive Chairman150,000N/A
Prof. Eli Hazum Ph.D.Chief Technology Officer & Director144,000N/A
Mr. Eyal BroderInterim Chief Financial Officer235,0001971
Ms. Rita KeynanVice President of Pharmaceutical Operations287,0001969
Dr. Sigal Aviel eMBA, Ph.D.Chief Operating Officer330,0001964
Dr. Stephen A. Cooper D.M.D Ph.D.Executive Vice President of Development0N/A

Description

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.